Company Pay Ratios
Publicly traded companies are required to disclose the pay ratio between their chief executive officers and median employees. High CEO-to-worker pay ratios contribute to economic inequality and can undermine employee morale and productivity. The average S&P 500 company’s CEO-to-worker pay ratio was 272-to-1 in 2022.
Ticker | Company | Median Worker Pay Sort descending | Pay Ratio |
---|---|---|---|
AGIO | Agios Pharmaceuticals, Inc. | $251,489 | 50:1 |
TXG | 10x Genomics, Inc. | $252,567 | 74:1 |
MEIP | Mei Pharma, Inc. | $252,808 | 10:1 |
APO | Apollo Asset Management, Inc. | $253,242 | 48:1 |
ATRA | Atara Biotherapeutics, Inc. | $254,363 | 20:1 |
FATE | Fate Therapeutics Inc. | $254,537 | 32:1 |
AFRM | Affirm Holdings, Inc. | $255,872 | 2:1 |
ACAD | Acadia Pharmaceuticals Inc. | $256,317 | 55:1 |
INSM | Insmed Inc. | $256,516 | 30:1 |
RNA | Avidity Biosciences, Inc. | $256,916 | 21:1 |
BCRX | Biocryst Pharmaceuticals Inc. | $258,689 | 27:1 |
NBIX | Neurocrine Biosciences Inc. | $262,049 | 45:1 |
BEAM | Beam Therapeutics Inc. | $262,700 | 36:1 |
CG | Carlyle Group Inc. | $263,098 | 156:1 |
NTLA | Intellia Therapeutics, Inc. | $264,161 | 38:1 |
HZNP | Horizon Therapeutics Public Ltd Co | $264,751 | 76:1 |
IRWD | Ironwood Pharmaceuticals Inc. | $265,137 | 30:1 |
AUPH | Aurinia Pharmaceuticals Inc. | $265,164 | 33:1 |
HASI | Hannon Armstrong Sustainable Infrastructure Capital, Inc. | $265,484 | 30:1 |
HCP | Hashicorp, Inc. | $265,793 | 32:1 |
Pagination
NOTE: For companies with more than one CEO during the year, the highest-paid CEO is included in the database. Pay ratio between CEO pay and median employee pay are displayed as disclosed by each company’s proxy statement. The CEO pay ratio may not equal the displayed CEO’s total compensation due to differing company methodologies in calculating pay ratios.
Terms and Data Sources | Contact the Press Office